Ann Marie Navar, MD
Dr. Navar is an Assistant Professor of Medicine (Cardiology), prevention researcher, and director of innovations at the Duke Clinical Research Institute. Her research is focused on preventing cardiovascular disease through blood pressure and cholesterol lowering, implementation science, risk communication, and EHR-enabled tools.
Lora E. Burke, PhD, MPH, FAHA, FAAN
Dr. Burke is a professor of nursing and epidemiology at the University of Pittsburgh and has secondary appointments in the Graduate School of Public Health, Department of Epidemiology and the Clinical Translation Science Institute. She also serves as the Director of the Hub for Excellence in eHealth Research in the School of Nursing. She has a long-standing record of NIH funding to support her research program, which includes a series of clinical trials focused on behavioral strategies to improve adherence to treatment regimens targeting cardiovascular disease risk reduction and long-term weight loss. She has incorporated the use of mobile technology to validate self-report measures for over 15 years. In her most recent study, she used ecological momentary assessment (EMA) to collect real-time data to study the triggers of weight regain over a 12-month intervention period. Currently, her team is testing an algorithm for the delivery of personalized, real-time feedback in response to self-monitoring lifestyle behaviors in a new clinical trial that aims to improve sustained engagement and long-term maintenance of behavior change. Her work has been recognized by The Obesity Society’s mHealth Interest Group’s Pioneer Award for Excellence in eHealth/mHealth Research.
Dr. Burke has been a longstanding AHA volunteer and earlier served as the Chair of the Council on Lifestyle and Cardiometabolic Health. She currently serves as the Immediate Past Chair of the Council Operations Committee and the also the Science of Behavior Change Sub-Committee.
Gabriel Castaño MD
Gabriel Castaño MD has a unique skill set as both a medical doctor and a biomedical engineer. He serves as a Senior Advisor to the Center for Health Technology and Innovation, proving input on the CarePlan development and the translation of CarePlans into Spanish. In addition to providing medical care in a primary care and pediatric setting, Dr. Castaño has been actively involved in health services research related to medical clinic productivity, value of care, and health literacy. Gabriel has co-founded and developed 2 health technology applications. Checkup is a phone and web based health care application designed to enhance doctor, patient interaction. ProyectoMETAS is a non-profit organization dedicated to promote health and well-being among children and families.
Aaron “Ronnie” Chatterji, Ph. D.
Aaron Chatterji, Ph.D. is an Associate Professor (with tenure) at Duke University’s Fuqua School of Business and Sanford School of Public Policy. He previously served as a Senior Economist at the White House Council of Economic Advisers (CEA) where he worked on a wide range of policies relating to entrepreneurship, innovation, infrastructure and economic growth. Chatterji has also been a visiting Associate Professor at Harvard Business School.
Chatterji’s research and teaching investigate some of the most important forces shaping our global economy and society: entrepreneurship, innovation, and the expanding social mission of business. He has received several awards, including the 2017 Kauffman Prize Medal for Distinguished Research in entrepreneurship, the Rising Star award from the Aspen Institute for his contributions to understanding the intersection of business and public policy, and the Strategic Management Society Emerging Scholar award for his research in strategy. He is also a Research Associate at the National Bureau of Economic Research.
His research has been published in leading academic journals and been cited by The New York Times, CNN, The Wall Street Journal, and The Economist. He has authored several op-ed pieces, including in the New York Times and the Wall Street Journal, appeared on national TV and radio, and has been profiled in The Financial Times and Fortune. Chatterji has also testified as an expert witness at the House Committee on Small Business and the U.S. Department of State and previously served as a Fellow at the Center for American Progress.
Chatterji serves as a board member for Durham Communities in Schools, an education-focused non-profit, and advises private, public and social sector organizations on innovation and strategy.
Chatterji is a term member of the Council on Foreign Relations and previously worked as a financial analyst at Goldman Sachs. He received his Ph.D. from the Haas School of Business at the University of California at Berkeley and his B.A. in Economics from Cornell University.
Animesh (Aashoo) Tandon, MD, MS
Animesh (Aashoo) Tandon, MD, MS, is practicing pediatric cardiologist and Assistant Professor of Pediatrics, with joint appointments in Radiology and Biomedical Engineering, at UT Southwestern and Children’s Medical Center Dallas.
His current research interests focus on the development and use of wearable and other monitoring devices; the collection and analysis of big data through machine learning and the development of predictive analytics; 3D printing, 3D visualization, virtual reality, and augmented reality in congenital heart disease; and the use of cardiac MRI (CMR) to aid in noninvasive histology and the understanding of pathophysiology in pediatric cardiology.
Dr. Tandon graduated from Washington University in St. Louis with a BA in 2003. During his medical training at the University of Michigan Medical School, he performed a research fellowship at the NINDS/NIH through the Howard Hughes Medical Institute/NIH Research Scholars (Cloister) Program. Dr. Tandon completed his pediatric residency and categorical pediatric cardiology fellowship at Cincinnati Children’s Hospital Medical Center. During fellowship, he earned a Masters in Clinical and Translational Research from the University of Cincinnati. He then completed an advanced imaging fellowship at Children’s Healthcare of Atlanta/Emory University
Tracy Yu-Ping Wang
Tracy Yu-Ping Wang, MD, MHS, MSc, FACC, FAHA
Tracy Y. Wang, MD, MHS, MSc, is an Associate Professor of Medicine (Cardiology) at Duke University. A graduate of Yale University and Harvard Medical School, she holds an MSc degree (molecular biochemistry/biophysics) and an MHS degree (clinical research). After completing internal medicine residency training at Brigham and Women’s Hospital in Boston, she came to Duke University for cardiology fellowship training and obtained an MHS degree in Clinical Research. Since joining the faculty at Duke in 2008, Dr. Wang has maintained a focus on the quality of evidence-based cardiovascular care and its association with patient outcomes. She has been a leader in the development of several cardiovascular clinical trials and registries at the Duke Clinical Research Institute (DCRI). She also has multiple leadership roles within the American Heart Association and the American College of Cardiology. Dr. Wang remains a practicing noninvasive cardiologist with both inpatient and outpatient responsibilities. She has published and lectured widely on the care of patients with acute coronary syndrome and atrial fibrillation. She is currently the Associate Director of the DCRI Fellowship Program.
Dr. Majmudar is a practicing cardiologist and Associate Director, Healthcare Transformation Lab at Massachusetts General Hospital, and an Instructor at Harvard Medical School. He is an active member of the healthcare innovation and entrepreneurship community, with a specific interest in technology-enabled healthcare innovation. He was a founding member and chief clinical officer of Quanttus, Inc. a venture-backed medical wearables startup. He is also a lecturer in the Harvard-MIT HST Program, and co-faculty for the course Healthcare Ventures.
Dr. Majmudar attended Northwestern University Feinberg School of Medicine and then completed residency training in Internal Medicine at The Johns Hopkins Hospital, followed by a fellowship in Cardiology at the Brigham and Women’s Hospital and Duke University Medical Center. He also holds a patent and has had several publications in high-impact journals, such as Nature, Circulation, and Journal of Healthcare Delivery and Implementation Science.
Robert A. Harrington
Dr. Robert A. Harrington is an interventional cardiologist and the Arthur L. Bloomfield Professor of Medicine and Chairman of the Department of Medicine at Stanford University. Dr. Harrington was previously the Richard Sean Stack, MD Distinguished Professor and the Director of the Duke Clinical Research Institute (DCRI) at Duke University. His research interests include evaluating antithrombotic therapies to treat acute ischemic heart disease and to minimize the acute complications of percutaneous coronary procedures, studying the mechanism of disease of the acute coronary syndromes, understanding the issue of risk stratification in the care of patients with acute ischemic coronary syndromes, building local, national and international collaborations for the efficient conduct of innovative clinical research and trying to better understand and improve upon the methodology of clinical research. His research has been extensively funded through NIH, NIA, other peer reviewed agencies and private industry. Committed to training and mentorship, Harrington has served as the principal mentor for more than 20 post-doctoral clinical research fellows focused on cardiovascular research. He has authored more than 520 peer-reviewed manuscripts, reviews, book chapters, and editorials. Thomson Reuters lists him as one of the most cited investigators in clinical medicine from 2002-2014. He is a deputy editor of JAMA Cardiology and an editorial board member for the Journal of the American College of Cardiology. He has served as editor of five textbooks and is a senior editor of the 13th and 14th editions of Hurst’s The Heart, one of the leading textbooks of cardiovascular medicine. He has been a member of the NHLBI’s Clinical Trials Study Section and the IOM’s Working Group on Data Sharing. He served as a member of the NIH NCATS Advisory Council Working Group on the IOM CTSA Program. He is currently serving a second term as a member and the chair of the US Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee. Harrington was recently a member of the American College of Cardiology (ACC) Board of Trustees and is currently a member of the American Heart Association’s (AHA) Board of Directors and its Science Advisory and Coordinating Committee and served as the Chair for the AHA’s Scientific Sessions in 2013 and 2014. Harrington is a Fellow of the American College of Cardiology, the American Heart Association, the Society for Cardiac Angiography and Intervention, the European Society of Cardiology, the American College of Chest Physicians and the American College of Physicians. He is an elected member of the Association of American Physicians and the Association of University Cardiologists. In 2015, he was elected to membership in the National Academy of Medicine/Institute of Medicine. In 2016, he was named a Master of the American College of Cardiology. Harrington is a Fellow of the American College of Cardiology, the American Heart Association, the Society for Cardiac Angiography and Intervention, the European Society of Cardiology, the American College of Chest Physicians and the American College of Physicians. He is an elected member of the Association of American Physicians and the Association of University
Cardiologists. In 2015, he was elected to membership in the National Academy of Medicine/Institute of Medicine. In 2016, he was named a Master of the American College of Cardiology.
Lee Shapiro is Managing Partner at 7wire Ventures, an investment firm he co-founded over a decade ago. He is a member of the National Board of Directors of The American Heart Association, serves on the boards of Medidata Solutions [NASDAQ:MDSO], Tivity Health [NASDAQ:TVTY], and Aptus Health (a Merck subsidiary [NYSE:MRK]). He is also active with the 7wire portfolio and serves on the boards of Livongo Health, Ayogo Health, Carebox, Zest Health (Chairman), Modern Teacher (past Chairman) and Education Funding Partners.
As President of Allscripts [NASDAQ:MDRX] from 2001 through 2012, his leadership was central to over $4B in mergers, acquisitions and financings. He oversaw the company’s strategy, international operations, business development and partnerships, health plan initiatives and entrepreneurial business investments.
He is a member of the Northwestern’s Kellogg Innovation Network Advisory Board, the University of Chicago Innovation Fund Advisory Committee, The Qualcomm Life Advisory Council and is on the advisory board for the Center of Digital Innovation in Health in Beer-Sheva, Israel.
Lee has served as an officer and director of the Gastro-Intestinal Research Foundation (GIRF), where he is now on the advisory board. Lee earned his JD degree from The University of Chicago Law School and a BS in Accounting from The University of Illinois Urbana-Champaign.
Dennis A. Robbins
Dennis Robbins (M.P.H. Harvard, Ph.D., Boston College) is a prominent innovator, thought leader, and health activist. His distinguished career spans multiple sectors of health, wellness, health care, industry, medical and surgical devices and technology, disruptive innovation, ethics and policy. His initial work on patient-centric engagement and now person-centricity ™ has stimulated a major paradigmatic shift in how we think about health, healthcare, and next generation engagement across diverse ecosystems.
Dr. Robbins was a National Fund for Medical Education Fellow, Visiting Scholar and Research Fellow at Harvard. He has advised Presidential and White house commissions, the military health system, start-ups, two US Supreme Court Cases and chaired the PCMH 2.O national think tank where he created the concept of person-centricity™, to help people become and stay healthier while adding years to their lives and life to their years. He blends elements of health information technologies, ethics, behavioral economics, exercise physiology, sleep, mindfulness, and healthy eating to bend the sickness curve. He serves on the boards or advisory boards of several companies and national organizations including the Global Innovation and Leadership Council of Frost and Sullivan and the American Heart Assn’s Technology and Innovation Advisory Board.
Dr. Robbins was a major force in the early Hospice Movement and worked closely across both aisles and CMS in helping to promote the Hospice Medicare benefit. His legacy of nine books and more than 400 articles is complimented by a plethora keynote presentations and panels. He has been recognized in the national media in such publications as Forbes, Medical Economics, Modern Healthcare, Hospital Ethics, and Managed Healthcare Executive who depicted him as among the top ten keenest thinkers in Managed Care.
Alexis L. Beatty, MD, MAS, is a cardiologist at the VA Puget Sound Health Care system, a core investigator with the Seattle-Denver Center of Innovation for Veteran-Centered and Value-Driven Care, and an Acting Assistant Professor at the University of Washington. Dr. Beatty received her MD from Duke University and her MAS in Clinical Research from University of California, San Francisco. She completed a residency in Internal Medicine at Massachusetts General Hospital and fellowships in Cardiology and Preventive Cardiology at University of California, San Francisco. Dr. Beatty’s research interest is in cardiovascular disease prevention, particularly the use of mobile technology for cardiac rehabilitation.
Zubin Eapen, MD, MHS is an Associate Professor of Medicine at Duke University, Medical Director of the Duke Heart Failure Same Day Access Clinic, Department of Medicine Director of Education IT Innovations, and Department of Medicine Director of Clinical Improvement. He is also a member of Duke Clinical Research Institute Health Services Research Group and Assistant Faculty Director for the Center for Educational Excellence. Dr. Eapen obtained his medical degree and completed his residency and Cardiology Fellowship at Duke University. He serves as Electronic Media Editor for JACC: Heart Failure, Editor for the 14th edition of Hurst’s the Heart, and Chief Medical Officer for Pattern Health Technologies. His particular interests include improving care coordination, disease management, and quality of care using digital health tools.
“Michael V. McConnell, MD, MSEE is Head of Cardiovascular Health Innovations at Verily Life Sciences and Professor of Cardiovascular Medicine at Stanford School of Medicine, where he continues to see patients and teach in the Stanford Biodesign program. Dr. McConnell has clinical and research expertise in cardiovascular imaging, prevention, and mobile health. While at Stanford, he led the Cardiovascular MRI program, the Preventive Cardiology Clinic, and the MyHeart Counts cardiovascular mHealth ResearchKit study.
Dr. McConnell completed his BS and MS in EE/BioE at MIT, his MD at Stanford, and his Cardiovascular Medicine and Imaging Fellowships at Brigham and Women’s Hospital/Harvard Medical School. He has been the PI of multiple grants from the NIH and AHA, and is a Fellow of the AHA and ACC. He serves on the AHA’s Health Tech Advisory Board since its founding and is currently co-chair of AHA’s 2030 Goals Task Force. He also serves on the Physical Activity Standards working group for the Consumer Technology Association.”
Mintu Turakhia M.D. M.A.S. is a cardiac electrophysiologist, outcomes researcher, and Associate Professor of Medicine at Stanford University. In his clinical role, Dr. Turakhia performs invasive procedures, such as catheter ablation and device implantation, to treat heart rhythm disorders. Dr. Turakhia has an active, highly-funded clinical research program in Atrial Fibrillation and runs the scientific program for Stanford’s new Center for Digital Health. He is also the principal investigator of several multi-center trials to test digital health tools and wearable devices to screen and manage heart rhythm disorders and manage drug therapy. Dr. Turakhia is a Fellow of the American Heart Association, American College of Cardiology, and Heart Rhythm Society.
Eric D. Peterson
Eric D. Peterson, MD, MPH, FAHA, FACC
Dr. Peterson is the Fred Cobb, Distinguished Professor of Medicine in the Division of Cardiology, a DukeMed Scholar, and the Executive Director of the Duke Clinical Research Institute (DCRI). Dr. Peterson is a recognized leader in outcomes and quality research, with over 1000 peer-reviewed publications in the field. Dr. Peterson is the Principal Investigator of the NHLBI’s Coordinating Center for its Outcome Research Network, and the AHRQ Cardiovascular Center for Education and Research on Therapeutics (CERTs). He is also the PI of the Data Coordinating Centers’ for the Society of Thoracic Surgeons (STS) National Cardiac Surgery Database, the American College of Cardiology’s National Cardiac Database (ACC-NCDR) and the American Heart Association’s Get With the Guidelines Database (AHA GWTG). Dr. Peterson participates on multiple national committees, as well as CV guideline and performance measure development groups. Dr. Peterson is also a member of the American Society for Clinical Investigation (ASCI), the Association of American Physicians (AAP),and the Association of University Cardiologists (AUC). Dr. Peterson received the American Heart Association Meritorious Achievement Award. He is also a Contributing Editor on the Journal of the American Medical Association.